Karthikeyan Mythreye Selected Research

betaglycan (TGFBR3)

1/2021	A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors.
1/2018	Dually modified transmembrane proteoglycans in development and disease.
12/2016	Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling.
11/2013	Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.
8/2011	Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines.
5/2011	The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells.
5/2009	The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karthikeyan Mythreye Research Topics

Disease

24	Neoplasms (Cancer) 11/2022 - 05/2009
9	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 01/2018
7	Neoplasm Metastasis (Metastasis) 11/2022 - 08/2011
3	Ascites 11/2022 - 01/2019
2	Adenocarcinoma 01/2020 - 01/2019
2	Carcinogenesis 11/2017 - 11/2015
1	Hypoxia (Hypoxemia) 01/2022
1	Colonic Neoplasms (Colon Cancer) 12/2018
1	Ischemia 02/2017
1	Neuroblastoma 11/2013
1	Vascular Remodeling 08/2012
1	Hematologic Neoplasms (Hematological Malignancy) 05/2011
1	Multiple Myeloma 05/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2009
1	Chromosome Breakage 03/2003

Drug/Important Bio-Agent (IBA)

7	betaglycan (TGFBR3)IBA 01/2021 - 05/2009
6	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 08/2013
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022 - 11/2013
4	LigandsIBA 01/2022 - 12/2016
4	AntioxidantsIBA 01/2022 - 11/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2013
3	EnzymesIBA 11/2022 - 11/2017
3	Inhibins (Inhibin)IBA 01/2022 - 01/2018
3	EndoglinIBA 01/2021 - 08/2012
3	Proteins (Proteins, Gene)FDA Link 11/2015 - 10/2009
3	Transforming Growth Factor beta (TGF-beta)IBA 08/2012 - 05/2009
2	CytokinesIBA 11/2022 - 01/2019
2	Activins (Activin)IBA 01/2022 - 01/2021
2	inhibin AIBA 01/2022 - 01/2018
2	Oxidants (Oxidizing Agents)IBA 01/2020 - 11/2017
2	CateninsIBA 12/2018 - 12/2016
2	Phosphotransferases (Kinase)IBA 12/2018 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 11/2017
2	Proteoglycans (Proteoglycan)IBA 12/2016 - 11/2009
1	ChemokinesIBA 11/2022
1	Long Noncoding RNAIBA 11/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2022
1	PlasticsIBA 02/2022
1	superoxide dismutase 2IBA 01/2022
1	Superoxide DismutaseIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2021
1	AnthracyclinesIBA 01/2021
1	taxaneIBA 01/2021
1	Sirtuin 3IBA 01/2020
1	IronIBA 01/2019
1	Glutathione PeroxidaseIBA 01/2019
1	Pharmaceutical PreparationsIBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 12/2018
1	MicroRNAs (MicroRNA)IBA 12/2018
1	Matrix Metalloproteinase InhibitorsIBA 12/2018
1	AntibodiesIBA 01/2018
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Syndecan-1 (Syndecan 1)IBA 01/2018
1	Superoxides (Superoxide)IBA 11/2017
1	chondroitin sulfate glycosaminoglycanIBA 12/2016
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 12/2016
1	Heparitin Sulfate (Heparan Sulfate)IBA 12/2016
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2013
1	Messenger RNA (mRNA)IBA 11/2013
1	Monomeric GTP-Binding ProteinsIBA 08/2013
1	Myosin Type IIIBA 08/2011
1	Peptide Hydrolases (Proteases)FDA Link 08/2011
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 05/2009
1	DNA (Deoxyribonucleic Acid)IBA 03/2003

Therapy/Procedure

9	Therapeutics 11/2022 - 08/2011
1	Isogeneic Transplantation 11/2022
1	Drug Therapy (Chemotherapy) 01/2021